Trial Details

COMPLETED
Basic Information
Clinical ID c393
Identifier NCT06676514
Trial Title Study to Evaluate the Treatment Benefits of Probiotic Clostridium Butyricum CBM588® for IBS-D
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions IBS-D (Diarrhea-predominant)
Interventions DIETARY_SUPPLEMENT: Probiotic Clostridium butyricum CBM588®|OTHER: Standard of care IBS-D treatment
Participant Information
Sponsor Liaquat University of Medical & Health Sciences
City Itala
Country/Region Italy
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase NA
Time Information
Start Date 2024-11-10
Primary Completion Date 2025-02-24
Completion Date 2025-03-10